School of Medicine - LSU Health New Orleans
HF, heart failure; LVEF, left ventricular ejection fraction. The primary randomised controlled trial of haemodynamic support with intravascular microaxial ventricular assist device (Impella 2.5) versus IABP in non-emergent HR-PCI (PROTECT-II) included patients who had an unprotected left main or last patent coronary vessel with an LVEF ≤35%. ................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.